|By PR Newswire||
|April 17, 2014 12:39 PM EDT||
LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
MediPoint: Biopsy Devices - US Analysis and Market Forecasts
MediPoint: Biopsy Devices - US Analysis and Market Forecasts
Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions.
While the global biopsy devices market is expected to see growth over the forecast period, there are several barriers that are dampening the intervention's potential adoption levels. Notably in the US, reimbursement for image guided breast biopsies has undergone some restructuring. The 2014 Medicare Fee Schedule Final Rule imposed drastic reimbursement cuts for these procedures which will have a significant effect on the adoption of more expensive vacuum assisted biopsy (VAB) devices.
- An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized the US biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019.
- Investigation of current and future market competition for biopsy devices
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the biopsy devices sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL).
Reasons to buy
- Understand the trends shaping and driving the US biopsy devices Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the US biopsy devices market through 2019.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in the US biopsy devices market landscape? Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 12
2.1 Overview 12
2.2 Catalyst 13
2.3 Related Reports 13
3 Industry Overview 14
3.1 Types of Biopsies 14
3.1.1 Surgical Biopsy 14
3.1.2 Fine Needle Aspiration 14
3.1.3 Core Needle Biopsy 15
3.1.4 Vacuum-Assisted Biopsy 16
3.2 Biopsy Procedure Trends 16
3.2.1 United States 16
3.3 Market Access to Cancer Screening Programs 18
3.3.1 Regulation 18
3.3.2 Biopsy Device Adoption Patterns 21
3.3.3 Reimbursement Trends 25
3.4 Regulatory Issues/Recalls 27
3.5 Mergers & Acquisitions/Key Partnerships 28
3.5.1 Hologic Acquires Suros Surgical Systems 28
3.5.2 C. R. Bard Acquires SenoRx 28
3.5.3 Devicor Medical Products Acquires Breast Care Portfolio from Ethicon Endo-Surgery 28
3.6 Economic Impact of Cancer Screening and Treatment 29
3.7 Additional Indications for Biopsy Devices 30
4 Unmet Needs 31
4.1 Overview 31
4.2 More Efficient Screening Tests for Prostate Cancer 31
4.3 More Efficient Screening Tests for Breast Cancer 32
4.4 More Efficient Screening Guidelines for Thyroid Cancer 32
4.5 Screening Tests That Can Provide Histological Analysis In Situ 33
5 Market Opportunity Analysis 34
5.1 Increase Marketing for Vacuum-Assisted Biopsy Devices in European Countries 34
5.2 Bundling Solutions 35
5.3 Focus Efforts on China's Increasing Adoption of VAB Devices 36
5.4 Market for Prostate Cancer Screening Coverage in Europe 36
6 Market Drivers and Barriers 38
6.1 Market Drivers 38
6.1.1 Inadequate Screening Tests for Particular Cancers 38
6.1.2 Demand for Minimally-Invasive Biopsy Techniques 39
6.1.3 Increased Adherence to Certain Cancer Screening Guidelines 39
6.1.4 Aging Patient Population 40
6.2 Market Barriers 41
6.2.1 Increased Competition from Other Cancer Diagnostic Tests 41
6.2.2 Breast Biopsy Reimbursement Bundling 44
6.2.3 Decreased Adherence to Certain Cancer Screening Guidelines 46
6.2.4 Benefits of Mass Prostate Cancer Screening Being Outweighed by Risks 47
7 Competitive Assessment 49
7.1 Overview 49
7.2 Classification Based on System 49
7.2.1 Vacuum-Assisted Biopsy Devices 49
7.2.2 Core Needle Biopsy Devices 51
7.2.3 Fine Needle Aspiration Devices 52
8 Pipeline Assessment 54
8.1 Overview 54
8.1.1 Optical Biopsy 54
8.1.2 Liquid Biopsy 56
9 Clinical Trial Analysis 57
10 Current and Future Players 59
10.1 Trends in Corporate Strategy 59
10.2 Company Profiles 59
10.2.1 Argon Medical Devices 59
10.2.2 Boston Scientific 62
10.2.3 Cardinal Health 64
10.2.4 CareFusion Corporation 66
10.2.5 Cook Medical 69
10.2.6 C. R. Bard 71
10.2.7 Devicor Medical Products 77
10.2.8 DTR Medical 81
10.2.9 Gallini Medical Devices 82
10.2.10 Hologic 85
10.2.11 INRAD 88
10.2.12 Intact Medical Corporation 90
10.2.13 TSK Laboratory 91
11 Market Outlook 94
11.1 Company Market Share 94
11.1.1 Vacuum-Assisted Biopsy Market Share 94
11.1.2 Core Needle Biopsy/Fine Needle Aspiration Market Share 96
11.2 By Geography 97
11.2.1 United States 97
12 Appendix 99
12.1 Bibliography 99
12.2 Abbreviations 108
12.3 Report Methodology 110
12.3.1 Overview 110
12.3.2 Coverage 110
12.3.3 Primary Research 110
12.3.4 Secondary Research 111
12.3.5 Forecasting Methodology 112
12.4 Key Opinion Leaders Included in This Study 112
12.5 About the Authors 113
12.5.1 Joseph A. Gregory, Analyst, Surgical Devices 113
12.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 113
12.6 Global Head of Healthcare 114
12.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 114
12.7 About MediPoint 115
12.8 About GlobalData 115
12.9 Disclaimer 115
List of Tables
Table 1: Biopsy Device Adoption Patterns in Diagnosing Prostate Cancer, Global, 2013 and 2019 22
Table 2: Biopsy Device Adoption Patterns in Diagnosing Breast Cancer, Global, 2013 and 2019 23
Table 3: Biopsy Device Adoption Patterns in Diagnosing Lung Cancer, Global, 2013 and 2019 24
Table 4: Biopsy Device Adoption Patterns in Diagnosing Liver Cancer, Global, 2013 and 2019 24
Table 5: Biopsy Device Adoption Patterns in Diagnosing Thyroid Cancer, Global, 2013 and 2019 25
Table 6: Age Demographics, Age >65 Years, Global, 2013 40
Table 7: Stereotactic Breast Biopsy Ambulatory Surgery Center Billing, 2011 45
Table 8: Stereotactic Breast Biopsy Physician Billing, 2011 45
Table 9: Company Profile - Argon Medical Devices 60
Table 10: Product Portfolio - Argon Medical Devices 61
Table 11: Argon Medical Devices, SWOT Analysis, 2013 61
Table 12: Company Profile - Boston Scientific 62
Table 13: Product Portfolio - Boston Scientific 63
Table 14: Boston Scientific SWOT Analysis, 2013 64
Table 15: Company Profile - Cardinal Health 65
Table 16: Product Portfolio - Cardinal Health 65
Table 17: Cardinal Health SWOT Analysis, 2013 66
Table 18: Company Profile - CareFusion Corporation 67
Table 19: Product Portfolio - CareFusion 68
Table 20: CareFusion, SWOT Analysis, 2013 68
Table 21: Company Profile - Cook Medical 69
Table 22: Product Portfolio - Cook Medical 70
Table 23: Cook Medical, SWOT Analysis, 2013 71
Table 24: Company Profile - C. R. Bard 72
Table 25: Product Portfolio - C. R. Bard 72
Table 26: C.R. Bard, SWOT Analysis, 2013 76
Table 27: Company Profile - Devicor Medical Products 77
Table 28: Product Portfolio - Devicor Medical Products 80
Table 29: Devicor Medical Products SWOT Analysis, 2013 80
Table 30: Company Profile - DTR Medical 81
Table 31: Product Portfolio - DTR Medical 81
Table 32: DTR Medical SWOT Analysis, 2013 82
Table 33: Company Profile - Gallini Medical Devices 83
Table 34: Product Portfolio - Gallini Medical Devices 84
Table 35: Gallini Medical Devices SWOT Analysis, 2013 84
Table 36: Company Profile - Hologic 85
Table 37: Product Portfolio - Hologic 87
Table 38: Hologic SWOT Analysis, 2013 87
Table 39: Company Profile - INRAD 88
Table 40: Product Portfolio - INRAD 89
Table 41: INRAD SWOT Analysis, 2013 89
Table 42: Company Profile - Intact Medical Corporation 90
Table 43: Product Portfolio - Intact Medical Corporation 91
Table 44: Intact Medical Corporation SWOT Analysis, 2013 91
Table 45: Company Profile - TSK Laboratory 92
Table 46: Product Portfolio - TSK Laboratory 92
Table 47: TSK Laboratory SWOT Analysis, 2013 93
Table 48: VAB, Global Market Share, 2013 95
Table 49: CNB/FNA, Global Market Share, 2013 96
Table 50: United States Biopsy Devices Sales ($m) Forecast, 2010-2019 97
List of Figures
Figure 1: Biopsy Procedure Volumes: All Indications, United States, 2010-2019 18
Figure 2: EnCor Breast Biopsy System 73
Figure 3: EnCor Enspire Breast Biopsy System 74
Figure 4: EnCor Ultra Breast Biopsy System 74
Figure 5: Finesse Ultra Breast Biopsy System 75
Figure 6: Vacora Breast Biopsy System 76
Figure 7: Original Mammotome System 78
Figure 8: Mammotome Elite 79
Figure 9: Mammotome Revolve 80
Figure 10: VAB, Global Market Share, 2013 95
Figure 11: CNB/FNA, Global Market Share, 2013 96
Figure 12: United States Biopsy Devices Sales ($) Forecast, 2010-2019 98
Read the full report:
MediPoint: Biopsy Devices - US Analysis and Market Forecasts
For more information:
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
The cloud competition for database hosts is fierce. How do you evaluate a cloud provider for your database platform? In his session at 18th Cloud Expo, Chris Presley, a Solutions Architect at Pythian, gave users a checklist of considerations when choosing a provider. Chris Presley is a Solutions Architect at Pythian. He loves order – making him a premier Microsoft SQL Server expert. Not only has he programmed and administered SQL Server, but he has also shared his expertise and passion with b...
Dec. 3, 2016 08:00 PM EST Reads: 3,944
In his session at 19th Cloud Expo, Claude Remillard, Principal Program Manager in Developer Division at Microsoft, contrasted how his team used config as code and immutable patterns for continuous delivery of microservices and apps to the cloud. He showed how the immutable patterns helps developers do away with most of the complexity of config as code-enabling scenarios such as rollback, zero downtime upgrades with far greater simplicity. He also demoed building immutable pipelines in the cloud ...
Dec. 3, 2016 08:00 PM EST Reads: 1,737
As data explodes in quantity, importance and from new sources, the need for managing and protecting data residing across physical, virtual, and cloud environments grow with it. Managing data includes protecting it, indexing and classifying it for true, long-term management, compliance and E-Discovery. Commvault can ensure this with a single pane of glass solution – whether in a private cloud, a Service Provider delivered public cloud or a hybrid cloud environment – across the heterogeneous enter...
Dec. 3, 2016 06:15 PM EST Reads: 1,506
"IoT is going to be a huge industry with a lot of value for end users, for industries, for consumers, for manufacturers. How can we use cloud to effectively manage IoT applications," stated Ian Khan, Innovation & Marketing Manager at Solgeniakhela, in this SYS-CON.tv interview at @ThingsExpo, held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 3, 2016 05:30 PM EST Reads: 4,035
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
Dec. 3, 2016 05:15 PM EST Reads: 2,132
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Onalytica. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
Dec. 3, 2016 05:15 PM EST Reads: 1,996
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
Dec. 3, 2016 04:30 PM EST Reads: 1,469
Predictive analytics tools monitor, report, and troubleshoot in order to make proactive decisions about the health, performance, and utilization of storage. Most enterprises combine cloud and on-premise storage, resulting in blended environments of physical, virtual, cloud, and other platforms, which justifies more sophisticated storage analytics. In his session at 18th Cloud Expo, Peter McCallum, Vice President of Datacenter Solutions at FalconStor, discussed using predictive analytics to mon...
Dec. 3, 2016 04:00 PM EST Reads: 4,857
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
Dec. 3, 2016 03:30 PM EST Reads: 1,584
Information technology is an industry that has always experienced change, and the dramatic change sweeping across the industry today could not be truthfully described as the first time we've seen such widespread change impacting customer investments. However, the rate of the change, and the potential outcomes from today's digital transformation has the distinct potential to separate the industry into two camps: Organizations that see the change coming, embrace it, and successful leverage it; and...
Dec. 3, 2016 03:15 PM EST Reads: 3,220
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
Dec. 3, 2016 03:00 PM EST Reads: 468
The Internet of Things (IoT) promises to simplify and streamline our lives by automating routine tasks that distract us from our goals. This promise is based on the ubiquitous deployment of smart, connected devices that link everything from industrial control systems to automobiles to refrigerators. Unfortunately, comparatively few of the devices currently deployed have been developed with an eye toward security, and as the DDoS attacks of late October 2016 have demonstrated, this oversight can ...
Dec. 3, 2016 02:45 PM EST Reads: 689
Extracting business value from Internet of Things (IoT) data doesn’t happen overnight. There are several requirements that must be satisfied, including IoT device enablement, data analysis, real-time detection of complex events and automated orchestration of actions. Unfortunately, too many companies fall short in achieving their business goals by implementing incomplete solutions or not focusing on tangible use cases. In his general session at @ThingsExpo, Dave McCarthy, Director of Products...
Dec. 3, 2016 02:45 PM EST Reads: 518
Regulatory requirements exist to promote the controlled sharing of information, while protecting the privacy and/or security of the information. Regulations for each type of information have their own set of rules, policies, and guidelines. Cloud Service Providers (CSP) are faced with increasing demand for services at decreasing prices. Demonstrating and maintaining compliance with regulations is a nontrivial task and doing so against numerous sets of regulatory requirements can be daunting task...
Dec. 3, 2016 02:45 PM EST Reads: 713
Fact: storage performance problems have only gotten more complicated, as applications not only have become largely virtualized, but also have moved to cloud-based infrastructures. Storage performance in virtualized environments isn’t just about IOPS anymore. Instead, you need to guarantee performance for individual VMs, helping applications maintain performance as the number of VMs continues to go up in real time. In his session at Cloud Expo, Dhiraj Sehgal, Product and Marketing at Tintri, sha...
Dec. 3, 2016 02:45 PM EST Reads: 783